Los Angeles Capital Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-93,250
| Closed | -$4.32M | – | 1434 |
|
|
2019
Q2 | $4.32M | Sell |
93,250
-25,605
| -22% | -$719K | 0.02% | 467 |
|
|
2019
Q1 | $2.9M | Buy |
118,855
+75,525
| +174% | +$1.57M | 0.02% | 547 |
|
|
2018
Q4 | $617K | Sell |
43,330
-29,890
| -41% | -$453K | ﹤0.01% | 904 |
|
|
2018
Q3 | $1.11M | Sell |
73,220
-78,545
| -52% | -$1.2M | 0.01% | 835 |
|
|
2018
Q2 | $2.55M | Buy |
151,765
+35,040
| +30% | +$557K | 0.01% | 633 |
|
|
2018
Q1 | $1.91M | Buy |
+116,725
| New | +$1.87M | 0.01% | 648 |
|
|
2017
Q4 | – | Sell |
-108,815
| Closed | -$1.34M | – | 1440 |
|
|
2017
Q3 | $1.34M | Buy |
108,815
+95,700
| +730% | +$889K | 0.01% | 728 |
|
|
2017
Q2 | $110K | Buy |
+13,115
| New | +$107K | ﹤0.01% | 1176 |
|
|
2016
Q4 | – | Sell |
-258,935
| Closed | -$1.75M | – | 1276 |
|
|
2016
Q3 | $1.75M | Sell |
258,935
-1,525
| -0.6% | -$5.9K | 0.01% | 601 |
|
|
2016
Q2 | $927K | Sell |
260,460
-12,860
| -5% | -$41.9K | 0.01% | 722 |
|
|
2016
Q1 | $806K | Sell |
273,320
-7,500
| -3% | -$22.5K | 0.01% | 690 |
|
|
2015
Q4 | $1.19M | Buy |
280,820
+265,080
| +1,684% | +$1.21M | 0.01% | 631 |
|
|
2015
Q3 | $72K | Buy |
+15,740
| New | +$93.3K | ﹤0.01% | 1141 |
|
Other funds holding ARRY
Los Angeles Capital Management's ARRY Position: Q3 2019 in Review
Los Angeles Capital Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 93,250 shares — an estimated $4.32M sold.
Los Angeles Capital Management first reported a position in ARRY in Q3 2015 and held it in 13 quarters. The position peaked at $4.32M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Los Angeles Capital Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Los Angeles Capital Management sold 93,250 Array Biopharma Inc shares in Q3 2019, an estimated $4.32M.
- Los Angeles Capital Management first reported a position in Array Biopharma Inc in Q3 2015 and held it in 13 quarters.
- Los Angeles Capital Management's Array Biopharma Inc position peaked at $4.32M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Los Angeles Capital Management's 13F filing for Q3 2019, filed 7 Nov 2019.